Login / Signup

University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol.

Anne Françoise DonneauMichèle GuillaumeVincent BoursMargaux DandoyGilles DarcisDaniel DesmechtAnh Nguvet DiepLaurence FievezMutien-Marie GariglianyNicolas GillainEddy HussonFabienne MichelMichel MoutschenMarine ParidansPétre BenoîtCatherine SabatelClaude SaegermanAmandine TytgatLaurent GilletFabrice Bureau
Published in: BMJ open (2022)
The study has received the approval from the University Hospital of Liège Ethics Committee (reference number 2021/96, dated 26 March 2021). Potential protocol amendments will be presented to the Research Ethics Committee. The findings of the present study will be presented at scientific conferences and the results published in peer-review publications. Weekly reports will be submitted to the risk assessment group and the risk management group against COVID-19 of the university to enable a timely public health action if necessary.
Keyphrases
  • public health
  • risk assessment
  • study protocol
  • sars cov
  • clinical trial
  • big data
  • emergency department
  • human health
  • global health
  • climate change
  • deep learning
  • respiratory syndrome coronavirus